Manufacture of pharmaceutical preparations
PROPHYLIX PHARMA HOLDING AS
Operating profit
NOK −71,000
Equity
NOK 2.2m
Incorporated
2017
Share capital
NOK 609,000
Roles
Regnskapsfører
Styrets lederKarl Johan Jakola
StyremedlemSveinung Hole
Shareholders
This list is shortened — open the ownership graph to see them all.
| Name | Stake | Shares | Year |
|---|---|---|---|
| TROND MOHN FORSKNINGSSTIFTELSE | 15.5% | 94463.000000 | 2025 |
| NORINNOVA INVEST AS | 10.8% | 65894.000000 | 2025 |
| NORINNOVA INVEST AS | 9.1% | 55388.000000 | 2025 |
| SARSIA SEED AS | 6.4% | 38957.000000 | 2025 |
| NORINNOVA INVEST AS | 5.8% | 35394.000000 | 2025 |
| SARSIA SEED AS | 5.8% | 35394.000000 | 2025 |
| NORINNOVA INVEST AS | 5.7% | 34871.000000 | 2025 |
| NORINNOVA AS | 5.5% | 33334.000000 | 2025 |
| UNIVERSITETSSYKEHUSET NORD-NORGE HF | 4.9% | 30001.000000 | 2025 |
| SARSIA SEED AS | 3.6% | 21965.000000 | 2025 |
| SARSIA SEED AS | 3.3% | 19926.000000 | 2025 |
| KRAKR AS | 2.0% | 12436.000000 | 2025 |
| BJØRN RAGNAR SKOGEN | 2.0% | 11933.000000 | 2025 |
| NORINNOVA AS | 1.9% | 11742.000000 | 2025 |
| METTE KJÆR | 1.8% | 10991.000000 | 2025 |
| BO JESPER HANSEN | 1.8% | 10982.000000 | 2025 |
| METTE KJÆR | 1.8% | 10733.000000 | 2025 |
| NORINNOVA AS | 1.5% | 9184.000000 | 2025 |
| ANNE HUSEBEKK | 1.4% | 8333.000000 | 2025 |
| JENS KJELDSEN-KRAGH | 1.1% | 6567.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| PROPHYLIX AS | Active | 100.0% | 1.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.